133 related articles for article (PubMed ID: 9219750)
1. [18F]fluorodopa PET shows striatal dopaminergic dysfunction in juvenile neuronal ceroid lipofuscinosis.
Ruottinen HM; Rinne JO; Haaparanta M; Solin O; Bergman J; Oikonen VJ; Järvelä I; Santavuori P
J Neurol Neurosurg Psychiatry; 1997 Jun; 62(6):622-5. PubMed ID: 9219750
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography shows reduced striatal dopamine D1 but not D2 receptors in juvenile neuronal ceroid lipofuscinosis.
Rinne JO; Ruottinen HM; Någren K; Aberg LE; Santavuori P
Neuropediatrics; 2002 Jun; 33(3):138-41. PubMed ID: 12200743
[TBL] [Abstract][Full Text] [Related]
3. Decreased striatal dopamine transporter density in JNCL patients with parkinsonian symptoms.
Aberg L; Liewendahl K; Nikkinen P; Autti T; Rinne JO; Santavuori P
Neurology; 2000 Mar; 54(5):1069-74. PubMed ID: 10720276
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of a dopamine transporter PET ligand [(18)F]beta-CFT in assessing disability in Parkinson's disease.
Rinne JO; Ruottinen H; Bergman J; Haaparanta M; Sonninen P; Solin O
J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):737-41. PubMed ID: 10567489
[TBL] [Abstract][Full Text] [Related]
5. Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study.
Rinne JO; Portin R; Ruottinen H; Nurmi E; Bergman J; Haaparanta M; Solin O
Arch Neurol; 2000 Apr; 57(4):470-5. PubMed ID: 10768619
[TBL] [Abstract][Full Text] [Related]
6. Young-onset Parkinson disease with and without parkin gene mutations: a fluorodopa F 18 positron emission tomography study.
Thobois S; Ribeiro MJ; Lohmann E; Dürr A; Pollak P; Rascol O; Guillouet S; Chapoy E; Costes N; Agid Y; Remy P; Brice A; Broussolle E;
Arch Neurol; 2003 May; 60(5):713-8. PubMed ID: 12756135
[TBL] [Abstract][Full Text] [Related]
7. Striatal dopamine transporter and extrapyramidal symptoms in frontotemporal dementia.
Rinne JO; Laine M; Kaasinen V; Norvasuo-Heilä MK; Någren K; Helenius H
Neurology; 2002 May; 58(10):1489-93. PubMed ID: 12034784
[TBL] [Abstract][Full Text] [Related]
8. Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease.
Scherfler C; Esterhammer R; Nocker M; Mahlknecht P; Stockner H; Warwitz B; Spielberger S; Pinter B; Donnemiller E; Decristoforo C; Virgolini I; Schocke M; Poewe W; Seppi K
Brain; 2013 Oct; 136(Pt 10):3028-37. PubMed ID: 24014521
[TBL] [Abstract][Full Text] [Related]
9. Progression of dopaminergic hypofunction in striatal subregions in Parkinson's disease using [18F]CFT PET.
Nurmi E; Bergman J; Eskola O; Solin O; Vahlberg T; Sonninen P; Rinne JO
Synapse; 2003 Jun; 48(3):109-15. PubMed ID: 12645035
[TBL] [Abstract][Full Text] [Related]
10. Alterations in striatal dopamine catabolism precede loss of substantia nigra neurons in a mouse model of juvenile neuronal ceroid lipofuscinosis.
Weimer JM; Benedict JW; Elshatory YM; Short DW; Ramirez-Montealegre D; Ryan DA; Alexander NA; Federoff HJ; Cooper JD; Pearce DA
Brain Res; 2007 Aug; 1162():98-112. PubMed ID: 17617387
[TBL] [Abstract][Full Text] [Related]
11. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
[TBL] [Abstract][Full Text] [Related]
12. Carbon monoxide poisoning-induced nigrostriatal dopaminergic dysfunction detected using positron emission tomography (PET).
Rissanen E; Paavilainen T; Virta J; Marttila RJ; Rinne JO; Airas L
Neurotoxicology; 2010 Aug; 31(4):403-7. PubMed ID: 20346372
[TBL] [Abstract][Full Text] [Related]
13. Age-dependent decline of nigrostriatal dopaminergic function: a positron emission tomographic study of grandparents and their grandchildren.
Cordes M; Snow BJ; Cooper S; Schulzer M; Pate BD; Ruth TJ; Calne DB
Ann Neurol; 1994 Oct; 36(4):667-70. PubMed ID: 7944302
[TBL] [Abstract][Full Text] [Related]
14. Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it?
Pirker W
Mov Disord; 2003 Oct; 18 Suppl 7():S43-51. PubMed ID: 14531046
[TBL] [Abstract][Full Text] [Related]
15. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.
Iranzo A; Valldeoriola F; Lomeña F; Molinuevo JL; Serradell M; Salamero M; Cot A; Ros D; Pavía J; Santamaria J; Tolosa E
Lancet Neurol; 2011 Sep; 10(9):797-805. PubMed ID: 21802993
[TBL] [Abstract][Full Text] [Related]
16. Nigral dysfunction in drug-induced parkinsonism: an 18F-dopa PET study.
Burn DJ; Brooks DJ
Neurology; 1993 Mar; 43(3 Pt 1):552-6. PubMed ID: 8451000
[TBL] [Abstract][Full Text] [Related]
17. Nigrostriatal dopaminergic function in familial amyotrophic lateral sclerosis patients with and without copper/zinc superoxide dismutase mutations.
Przedborski S; Dhawan V; Donaldson DM; Murphy PL; McKenna-Yasek D; Mandel FS; Brown RH; Eidelberg D
Neurology; 1996 Dec; 47(6):1546-51. PubMed ID: 8960743
[TBL] [Abstract][Full Text] [Related]
18. 18F-fluorodopa PET study of striatal dopamine uptake in the diagnosis of dementia with Lewy bodies.
Hu XS; Okamura N; Arai H; Higuchi M; Matsui T; Tashiro M; Shinkawa M; Itoh M; Ido T; Sasaki H
Neurology; 2000 Nov; 55(10):1575-7. PubMed ID: 11094120
[TBL] [Abstract][Full Text] [Related]
19. Striatal uptake of the dopamine reuptake ligand [11C]beta-CFT is reduced in Alzheimer's disease assessed by positron emission tomography.
Rinne JO; Sahlberg N; Ruottinen H; Någren K; Lehikoinen P
Neurology; 1998 Jan; 50(1):152-6. PubMed ID: 9443472
[TBL] [Abstract][Full Text] [Related]
20. [Presynaptic nigrostriatal function in Parkinson disease and Parkinson-plus syndromes. Comparative studies using positron emission tomography with L-6-(18F)fluorodopa].
Cordes M; Poewe W
Nervenarzt; 1994 Oct; 65(10):696-9. PubMed ID: 7808568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
